Evidence map›Paper›PMID 41072391›Full record

ReviewBiomaterials2026

Engineering biomimetic tissue barrier models on chips: From design and fabrication to applications in disease modeling and drug screening.

Rohollah Nasiri, Masoud Madadelahi, Mohammad Reza Nikmaneshi, Begum Gokce, Mohamad Ali Bijarchi, Shilp Shah, Zuzana Tirpáková, Dirkje Van Gastel, Nayere Taebnia, Natan Roberto de Barros and 12 more

Abstract readReview
In one paragraph

Review in Biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Advances in vascularized organoids.Chinese medical journal · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Rohollah NasiriDivision of Nanobiotechnology, Department of Protein Science, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden; AIMES, Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, Solna, Sweden; Division of Medical Physics, Department of Radiation Oncology, Stanford University, Stanford, CA, USA. Electronic address: [email protected].
Masoud MadadelahiSchool of Engineering and Sciences, Tecnológico de Monterrey, Ave. Eugenio Garza Sada 2501, Monterrey, 64849, NL, Mexico.
Mohammad Reza NikmaneshiEdwin L Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Begum GokceDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Turkey.
Mohamad Ali BijarchiHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 02138, USA.
Shilp ShahTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA.
Zuzana TirpákováTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA; Department of Biology and Physiology, University of Veterinary Medicine and Pharmacy in Kosice, Komenskeho 73, 04181, Kosice, Slovakia.
Dirkje Van GastelDivision of Nanobiotechnology, Department of Protein Science, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden; Department of Mechanical Engineering/Microsystem, Eindhoven University of Technology, 5612, AZ, Eindhoven, the Netherlands.
Nayere TaebniaDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Natan Roberto de BarrosTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA.
Yangzhi ZhuTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA.
Zehra Gul MorcimenDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Turkey.
Baris GulicliDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Turkey.
Rouhollah HabibeyDepartment of Ophthalmology, Medical Faculty, University of Bonn, Bonn, Germany.
Aylin SendemirDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Turkey; Department of Biomedical Technologies, Graduate School of Natural and Applied Sciences, Ege University, Turkey.
Saumey JainDivision of Nanobiotechnology, Department of Protein Science, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden; Division of Micro and Nanosystems, Department of Intelligent Systems, KTH Royal Institute of Technology, Stockholm, Sweden.
Alessandro EnricoDivision of Micro and Nanosystems, Department of Intelligent Systems, KTH Royal Institute of Technology, Stockholm, Sweden; Synthetic Physiology Lab, Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy.
Volker M LauschkeDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany.
Mehmet Remzi DokmeciTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA.
Guillem PratxDivision of Medical Physics, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Ali KhademhosseiniTerasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA. Electronic address: [email protected].
Anna HerlandDivision of Nanobiotechnology, Department of Protein Science, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden; AIMES, Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, Solna, Sweden. Electronic address: [email protected].

Funding

Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.UH3TR003148 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ASHAMMAKHI, NUREDDIN, MAIDMENT, NIGEL T · 2022 to 2024
$2.4M
Preclinical microphysiological tumor models for nuclear medicineR01CA268514 · NCI · STANFORD UNIVERSITY · PI Guillem Pratx, JOHN B SUNWOO · 2023 to 2026
$2.1M
Research Supplements to Promote DiversityR01GM126571 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DOKMECI, MEHMET REMZI, YE, JING YONG · 2018 to 2021
$1.3M
NCATS NIH HHS UH3 TR003148NCI NIH HHS R01 CA268514NIGMS NIH HHS R01 GM126571
6 · The paper itself

Abstract

Replicating the in vitro properties of tissue barriers-such as the blood-brain barrier, gut, skin, lung, kidney, retina, nasal epithelium, and placenta-is crucial for many applications, including drug screening, studying molecular transport, drug delivery, and disease modeling in preclinical studies. Organ-on-a-chip (OoC) platforms are advanced three-dimensional (3D) in vitro models that aim to replicate various aspects of organ functionality within microfluidic systems by providing microenvironments akin to native tissue. When used to model the interface between two different tissue compartments, OoC technology offers a promising platform for more accurately replicating the physiology and pathophysiology of various tissue barriers in the body. This review focuses on the state-of-the-art biomimetic tissue barrier models, ranging from two-channel tissue barrier-on-a-chip systems with a thin porous membrane to hydrogel-based membrane models. Specifically, it explores the engineering of tissue barrier-on-a-chip platforms, highlighting various fabrication techniques for microfluidic chips and membranes, as well as methods for functional characterization of the engineered tissue barriers. Additionally, we discuss the development of organ-specific barrier models and multi-organ-on-a-chip systems for studying inter-organ communication. Finally, we highlight the current challenges in the field and future directions in advancing tissue barrier modeling using OoC technology.

Indexed as

Biomimetic MaterialsBiomimeticsLab-On-A-Chip DevicesModels, BiologicalTissue EngineeringAnimalsDrug Evaluation, PreclinicalHumansMicrofluidic Analytical TechniquesDisease modelingDrug screeningDrug transportMembraneMicrofabricationMicrofluidicsOrgan-on-a-chipTissue-tissue interface

Identifiers

PMID41072391
PMCPMC12646612

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.